HomeDAWN • NASDAQ
add
Day One Biopharmaceuticals Inc
Previous close
$14.32
Day range
$13.30 - $14.35
Year range
$11.30 - $18.07
Market cap
1.34B USD
Avg Volume
1.22M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Investopedia
1 day ago
S&P 500 Gains and Losses Today: Palantir Stock Jumps as Listing Heads to
Nasdaq
11.10%
0.90%
1.32%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 93.76M | — |
Operating expense | 62.54M | 21.57% |
Net income | 37.04M | 180.25% |
Net profit margin | 39.50 | — |
Earnings per share | 0.38 | 170.37% |
EBITDA | 30.24M | 158.80% |
Effective tax rate | -2.44% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 558.38M | 37.69% |
Total assets | 600.81M | 45.06% |
Total liabilities | 45.34M | 84.69% |
Total equity | 555.46M | — |
Shares outstanding | 100.85M | — |
Price to book | 2.60 | — |
Return on assets | 14.80% | — |
Return on capital | 17.13% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 37.04M | 180.25% |
Cash from operations | 50.75M | 236.93% |
Cash from investing | -67.70M | -176.14% |
Cash from financing | 200.10M | 173,895.65% |
Net change in cash | 183.15M | 252.43% |
Free cash flow | -80.07M | -203.51% |
About
Founded
2018
Headquarters
Website
Employees
174
